Product Information
FT ALLERGY (DIPHEN) 25 MG CAP is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0534 per EA under NDC 70677101501. Its NADAC has been published 161 times since Sep 6, 2023.
Strength
25 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677101501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIPHENHYDRAMINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
4/6/2023
Pharmacological Classes
Price Statistics
The NADAC for FT ALLERGY (DIPHEN) 25 MG CAP has been published 161 times since Sep 6, 2023, and over the history we have for it it has risen 28.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0534 per EA |
|---|---|
| All-time high | $0.0640 (Feb 11, 2026) |
| All-time low | $0.0360 (Jul 17, 2024) |
| 52-week high | $0.0640 |
| 52-week low | $0.0528 |
| Median price | $0.0463 |
| Average price | $0.0480 |
| Largest weekly change | +12.6% (Oct 18, 2023) |
| Weeks tracked | 161 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diphenhydramine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ALLERGY (DIPHEN) 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for FT ALLERGY (DIPHEN) 25 MG CAP, manufactured by Strategic Sourcing Services LLC, is $0.0534 per EA (NDC 70677101501), effective Sep 30, 2026.
How has the price of FT ALLERGY (DIPHEN) 25 MG CAP changed over time?
Over the history we have for it, the NADAC for FT ALLERGY (DIPHEN) 25 MG CAP has risen 28.5%. It has been tracked across 161 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for FT ALLERGY (DIPHEN) 25 MG CAP?
Since Sep 6, 2023, the NADAC for FT ALLERGY (DIPHEN) 25 MG CAP has ranged from a low of $0.0360 (Jul 17, 2024) to a high of $0.0640 (Feb 11, 2026), with a median of $0.0463 per EA.
Are there cheaper alternatives to FT ALLERGY (DIPHEN) 25 MG CAP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DIPHENHYDRAMINE 25 MG CAPSULE, is $0.0311 per EA — about 42% below FT ALLERGY (DIPHEN) 25 MG CAP.
Who manufactures FT ALLERGY (DIPHEN) 25 MG CAP?
FT ALLERGY (DIPHEN) 25 MG CAP (NDC 70677101501) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.